The novel therapy of the medication represents a significant breakthrough in the handling of the condition. Distinct from existing medications, tirzepatide affects two pathways – GLP-1 and GIP – resulting in https://tirzepatide-peptide181224.canariblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56972903